Tenax Therapeutics
TENX
10 hedge funds and large institutions have $1.75M invested in Tenax Therapeutics in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 4 closing their positions.
20% more capital invested
Capital invested by funds: $1.46M → $1.75M (+$287K)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
17% less funds holding
Funds holding: 12 → 10 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$52.6K |
| 2 |
Renaissance Technologies
New York
|
+$46.7K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.95K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$29K |
| 2 |
VF
Virtu Financial
New York
|
-$21K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
-$12K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$11.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
BlackRock
New York
| $845K | – | – | – |
|
|
2
Renaissance Technologies
New York
| $632K | +$46.7K | +24 | +9% |
|
|
FWP
3
FAS Wealth Partners
Leawood,
Kansas
| $83K | – | – | – |
|
|
SM
4
Sabby Management
Miami Beach,
Florida
| $61K | +$52.6K | +27 | New |
|
5
Bank of New York Mellon
New York
| $50K | – | – | – |
|
6
Geode Capital Management
Boston,
Massachusetts
| $46K | – | – | – |
|
7
Vanguard Group
Malvern,
Pennsylvania
| $17K | – | – | – |
|
|
LTFS
8
Ladenburg Thalmann Financial Services
Miami,
Florida
| $7K | – | – | – |
|
|
AG
9
Advisor Group
Phoenix,
Arizona
| $4K | – | – | – |
|
|
10
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $2K | +$1.95K | +1 | New |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$29K | -15 | Closed |
|
|
VF
12
Virtu Financial
New York
| – | -$21K | -11 | Closed |
|
|
ARTA
13
A.R.T. Advisors
New York
| – | -$12K | -6 | Closed |
|
|
14
UBS Group
Zurich,
Switzerland
| – | -$11.7K | -6 | Closed |
|
TENX Hedge Fund Activity: Q4 2019 in Review
10 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q4 2019, worth a combined $1.75M — up 20% from $1.46M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of TENX and 2 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Sabby Management, opening a new position worth an estimated $52.6K. The largest seller was Citadel Advisors, exiting entirely with an estimated $29K sold.
- 10 institutional investors held Tenax Therapeutics (TENX) as of Q4 2019, down from 12 in Q3 2019.
- Funds reported $1.75M of Tenax Therapeutics stock for Q4 2019, up 20% quarter-over-quarter.
- 2 funds opened new Tenax Therapeutics positions in Q4 2019 and 4 closed out, a net change of -2 holders.
- The largest Tenax Therapeutics buyer in Q4 2019 was Sabby Management, an estimated $52.6K added.
- The largest Tenax Therapeutics seller in Q4 2019 was Citadel Advisors, an estimated $29K sold.
Based on aggregated 13F filings for Q4 2019.